匹格列酮、二甲双胍与房颤 噻唑烷二酮类(thiazolidinediones, TZDs)是胰岛素增敏剂,其多效性可能带来有益的心血管保护效应, 尤其是其抗炎和抗氧化机制。
基于152个网页-相关网页
胰岛素增敏剂噻唑烷二酮类(thiazolidine-diketone,TZD)药物如吡格列酮有减轻IR作用。本研究从T2DM胰岛β细胞功能进行性衰竭的多个原因入手,通过采用持续皮...
基于4个网页-相关网页
近年来, 新开发的胰岛素增敏剂—噻唑烷二酮类(thiazolidinyldio- nes,TZDs)药物,是一类具有很好发展前途的新型制剂。
基于4个网页-相关网页
噻唑烷二酮类药物 TZD ; thiazolidinediones ; Thiazoli dilsdioms ; thiazolidinedione compounds
配体噻唑烷二酮类 thiazolidinediones ; TZDS
噻唑烷二酮类化合物 Thiazoliddinediones ; TZDS ; Thiazolidineline
噻唑烷二酮类降糖药 thizolidinedione ; TZD
属噻唑烷二酮类 thiazolidinediones ; TZDS
的噻唑烷二酮类 thiazolidinediones ; TZDS
属于噻唑烷二酮类 thiazolidinediones ; TZDS
用的噻唑烷二酮类 thiazolidinediones ; TZDS
作用的噻唑烷二酮类 thiazolidinediones
Thiazolidinediones (TZDs) , PPAR Y ligands, are currently used in the treatment of type 2 diabetes mellitus because of their insulin-sensitizing effects and many others which remains unclear.
噻唑烷二酮类药物(TZD)是PPARγ的配体,具有增强胰岛素敏感性的作用,现广泛用于2型糖尿病的治疗。
参考来源 - PPARγ配体吡格列酮对糖尿病肾病的作用研究Whether rosiglitazone has this kind of effect on kidney and its mechanism are unknown.
罗格列酮属噻唑烷二酮类药物,它是否具有此类作用及其可能机制尚不明确。
参考来源 - 罗格列酮对阿霉素肾病大鼠肾小球硬化的保护作用·2,447,543篇论文数据,部分数据来源于NoteExpress
罗格列酮和吡咯列酮同属噻唑烷二酮类。
Rosiglitazone and pioglitazone are part of a group of drugs called thiazolidinediones.
评论:我们能从对噻唑烷二酮类的持续调控中学到什么?
Commentary: What can we learn from the continuing regulatory focus on the thiazolidinediones?
研究目的:已知噻唑烷二酮类药增加2型糖尿病患者心衰发病风险。
OBJECTIE - : Thiazolidinediones are known to increase the risk of heart failure in patients with type 2 diabetes.
应用推荐